AC Immune SA — Quarterly Financial Data (NASDAQ:ACIU) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

新闻

AC Immune startet Phase-1-Studie für hirngängigen NLRP3-Inhibitor

AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD

Tesla and Rivian among market cap stock movers on Friday

AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - AC Immune (NASDAQ:ACIU)

Positive Studiendaten zu Parkinson-Mittel beflügeln AC Immune-Aktie

AC Immune stock rises after positive Parkinson’s disease trial data

AC Immune’s Parkinson’s treatment shows promise in slowing disease

AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates

Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline